Sandu Pharmaceuticals

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue15.3017.6616.7017.4615.91
Expenses14.9417.4415.9217.0815.19
EBITDA0.520.350.910.540.91
EBIT0.400.230.780.400.73
Profit Before Tax0.370.210.760.380.71
Net Profit0.270.110.550.210.59
Financial Ratios
Operating Profit Margin3.47%2.04%5.48%3.10%5.83%
Net Profit Margin1.77%0.62%3.31%1.20%3.78%
Earning Per Share (Diluted)0.270.110.570.210.50
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ